Overcoming the challenges of the pharmaceutical industry

May 23, 2019

Ahead of the FT Pharmaceutical and Biotech Conference on 11-12 November 2019, we gathered some of the leading figures in the pharmaceutical industry at the Financial Times' headquarters for a morning of discussions on the key issues the industry is facing.

Spotlight

ZS Pharma, Inc.

From manufacturing to technology to people, ZS Pharma is thinking differently about developing therapies to address unmet needs. ZS Pharma was founded in 2008, became a public company in 2014 and, in December 2015, joined the AstraZeneca Group. We are a biopharmaceutical company dedicated to challenging the status quo in disease areas where therapeutic options have been limited. We are currently focused on using our proprietary ion-trap technology to develop new treatments. The ZS Pharma team combines deep knowledge and experience with an unparalleled drive to provide innovative new medicines for patients, families and physicians facing serious, difficult-to-treat diseases.

OTHER VIDEOS

Free flowing amorphous solid dispersions for enhanced drug solubility

video | March 9, 2022

Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology EUDRATEC® SoluFlow is just that! It works by turning a poorly soluble drug into a free-flowing amorphous solid dispersion (ASD) that can be easily compressed into tablets or filled into capsules....

Watch Now

Optimizing Outcomes Across the Pharma Value Chain Network

video | January 20, 2022

The pharma industry faces new challenges to be more agile and flexible in the effort to produce and deliver medicines to market faster. Digitalization will play a key role in helping companies optimize their value chain network. Hear from AspenTech's David Leitham as he touches on this trend and how Industrial AI solutions will help companies stay ahead....

Watch Now

How Billionaire Mark Cuban's Online Pharmacy Went From Pitch To Reality

video | February 2, 2022

Billionaire investor Mark Cuban launched an online pharmacy that offers more than 100 generic drugs at an affordable price with a goal of being “radically transparent” in its price negotiations with drug companies....

Watch Now

Digital Health solutions for patient centric clinical trials

video | August 24, 2021

Digital health solutions for remote patient data collection and continuous patient monitoring are enabling us to reduce patient burden and accelerate our clinical trials. Halsey Lea, Director Data Science, Data Science & AI, R&D, explains the transformative role that digital connected devices are playing in our smart clinical trial programmes....

Watch Now

Spotlight

ZS Pharma, Inc.

From manufacturing to technology to people, ZS Pharma is thinking differently about developing therapies to address unmet needs. ZS Pharma was founded in 2008, became a public company in 2014 and, in December 2015, joined the AstraZeneca Group. We are a biopharmaceutical company dedicated to challenging the status quo in disease areas where therapeutic options have been limited. We are currently focused on using our proprietary ion-trap technology to develop new treatments. The ZS Pharma team combines deep knowledge and experience with an unparalleled drive to provide innovative new medicines for patients, families and physicians facing serious, difficult-to-treat diseases.

Events